- This event has passed.
“Challenges and Opportunities for Osteoporosis Management” (Hybrid Event)
Roberto Civitelli, MD
Sydney M. & Stella H. Shoenberg Chair in Medicine
Washington University in St. Louis – John T. Milliken Department of Medicine
Roberto Civitelli, MD is a Professor of Medicine at Washington University in St. Louis, Missouri. Hailing from Siena, Italy, Dr. Civitelli has been affiliated with the Division of Bone and Mineral Diseases since 1985, serving as Division Chief for 15 years (2010-2024), and shaping its trajectory as a leading skeletal research, education and patient care center. As a physician-scientist, he has published over 200 original articles, reviews and book chapters and leads a dynamic bone biology program, supported by the NIH for over 30 years. As a clinician, Dr. Civitelli provides specialized treatment for individuals with metabolic bone disorders. He has held leadership positions in ASBMR, including President (2013-2014), and other international professional organizations. He has served as Editor-in-Chief of Calcified Tissue International (2001-2013) and the Journal of Bone and Mineral Research (2018-2022). His contributions as researcher and mentor have been acknowledged by prestigious awards, including the 2023 Gideon A. Rodan Excellence in Mentorship Award by ASBMR.
Dr. Civitelli’s OBJECTIVES:
- Appraise current armamentarium of pharmacologic therapies for osteoporosis.
- Assess the mechanisms of action of different osteoporosis medications.
- Evaluate current challenges of long-term therapy for osteoporosis.
- Interpret the appropriate use of sequential or combined regimens for osteoporosis.
Faculty Disclosures
Dr. Civitelli has indicated he does not have any relevant financial relationships with commercial interests.
Planning Committee Disclosure
Dr. Deshpande has indicated the following relevant financial relationships with commercial interests:
- Advisor – GI Health Foundation
Dr. Weiss has indicated the following relevant financial relationships with commercial interests:
- Advisor – Prizm LLC
- Advisor – Fortress Pharmaceuticals
Laura Pinzon has indicated she has no relevant financial relationships with commercial interests.
Target Audience
Primary care physicians.
Accreditation
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.”